Temozolomide

CAS No. 85622-93-1

Temozolomide ( NSC-362856;CCRG-81045;TZM )

Catalog No. M16206 CAS No. 85622-93-1

An alkylating agent used as a treatment of some brain cancers, astrocytoma and glioblastoma.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 38 In Stock
25MG 61 In Stock
50MG 74 In Stock
100MG 87 In Stock
200MG 116 In Stock
500MG 152 In Stock
1G 224 In Stock

Biological Information

  • Product Name
    Temozolomide
  • Note
    Research use only, not for human use.
  • Brief Description
    An alkylating agent used as a treatment of some brain cancers, astrocytoma and glioblastoma.
  • Description
    An alkylating agent used as a treatment of some brain cancers, astrocytoma and glioblastoma; a prodrug and an imidazotetrazine derivative of the alkylating agent dacarbazine.Chemotherapeutic Agents Approved
  • Synonyms
    NSC-362856;CCRG-81045;TZM
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    DNA Alkylator
  • Recptor
    DNAreplication
  • Research Area
    Cancer
  • Indication
    Chemotherapeutic

Chemical Information

  • CAS Number
    85622-93-1
  • Formula Weight
    194.15
  • Molecular Formula
    C6H6N6O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 33.33 mg/mL
  • SMILES
    O=C(C1=C(N2C=N1)N=NN(C)C2=O)N
  • Chemical Name
    Imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide, 3,4-dihydro-3-methyl-4-oxo-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Rao JU, et al. Sci Rep. 2017 Aug 11;7(1):7865.
2. Tateishi K, et al. Cancer Res. 2017 Aug 1;77(15):4102-4115.
3. Beier D, et al. Cancer Res. 2008 Jul 15;68(14):5706-15.
molnova catalog
related products
  • Bisantrene

    A small molecule DNA intercalater with antineoplastic activity, does not exhibit cardiotoxicity compared with doxorubicin; induces both protein-associated DNA single-strand breaks and DNA-protein crosslinks in cancer cells.

  • Streptozocin

    Streptozotocin is a DNA alkylating agent that enters cells exclusively via the GLUT2 glucose transport protein.

  • Melflufen

    Melflufen is a novel dipeptide and alkylating prodrug of melphalan, inhibits angiogenesis in vitro and in vivo; shows cytotoxic activity against lymphoma cell lines with IC50 of 0.011-0.92 uM, also shows significantly lower IC50 than melphalan in multiple myeloma cells.